Literature DB >> 30319325

Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy.

Octavi Cordoba1, Lourdes Carrillo-Guivernau2, Carmen Reyero-Fernández1.   

Abstract

Neoadjuvant therapy (NAT) allows downstaging in some cases of breast cancer. By consequence, it may enable a more conservative surgical approach or make surgery possible in cases ineligible for surgery before NAT. In this article, we review the evidence and management recommendations for optimal surgical treatment in this setting.

Entities:  

Keywords:  Breast cancer; Conservative treatment; Neoadjuvant therapy; Sentinel lymph node; Surgery

Year:  2018        PMID： 30319325      PMCID： PMC6167713          DOI： 10.1159/000491760

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


  66 in total

1.  The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.

Authors:  Rosalinda Alvarado; Min Yi; Huong Le-Petross; Michael Gilcrease; Elizabeth A Mittendorf; Isabelle Bedrosian; Rosa F Hwang; Abigail S Caudle; Gildy V Babiera; Jeri S Akins; Henry M Kuerer; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2012-07-07       Impact factor: 5.344

2.  Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.

Authors:  B Fisher; E Saffer; C Rudock; J Coyle; N Gunduz
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

3.  Comparison of the diagnostic performance of digital breast tomosynthesis and magnetic resonance imaging added to digital mammography in women with known breast cancers.

Authors:  Won Hwa Kim; Jung Min Chang; Hyeong-Gon Moon; Ann Yi; Hye Ryoung Koo; Hye Mi Gweon; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2015-09-16       Impact factor: 5.315

Review 4.  St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.

Authors:  Michael Gnant; Nadia Harbeck; Christoph Thomssen
Journal:  Breast Care (Basel)       Date:  2017-04-26       Impact factor: 2.860

5.  Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?

Authors:  Maxine S Jochelson; Katharine Lampen-Sachar; Girard Gibbons; Chau Dang; Diana Lake; Elizabeth A Morris; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2015-03-17       Impact factor: 5.344

6.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Authors:  Judy C Boughey; Vera J Suman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Henry M Kuerer; Monet Bowling; Teresa S Flippo-Morton; David R Byrd; David W Ollila; Thomas B Julian; Sarah A McLaughlin; Linda McCall; W Fraser Symmans; Huong T Le-Petross; Bruce G Haffty; Thomas A Buchholz; Heidi Nelson; Kelly K Hunt
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

7.  Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).

Authors:  Judy C Boughey; Karla V Ballman; Huong T Le-Petross; Linda M McCall; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; Eric C Feliberti; Kelly K Hunt
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

8.  Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.

Authors:  Christian Siso; Juan de Torres; Antonio Esgueva-Colmenarejo; Martin Espinosa-Bravo; Neus Rus; Octavi Cordoba; Roberto Rodriguez; Vicente Peg; Isabel T Rubio
Journal:  Ann Surg Oncol       Date:  2017-12-01       Impact factor: 5.344

9.  Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy.

Authors:  Stefano Santoro; Andrea Loreti; Francesco Cavaliere; Leopoldo Costarelli; Massimo La Pinta; Elena Manna; Maria Mauri; Paola Scavina; Elena Santini; Ugo De Paula; Vito Toto; Lucio Fortunato
Journal:  Breast       Date:  2015-09-03       Impact factor: 4.380

10.  Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.

Authors:  Jee Ye Kim; Hyung Seok Park; Sanghwa Kim; Jegyu Ryu; Seho Park; Seung Il Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817
View more
  3 in total

Review 1.  Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field.

Authors:  Santiago Escrivá-de-Romaní; Miriam Arumí; Esther Zamora; Meritxell Bellet
Journal:  Breast Care (Basel)       Date:  2018-08-14       Impact factor: 2.860

2.  Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.

Authors:  Anna Torrent; Joana Amengual; Catalina Maria Sampol; Mario Ruiz; Jorge Rioja; Gabriel Matheu; Pilar Roca; Octavi Cordoba
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

3.  Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments.

Authors:  Joana Reis; Jonas Christoffer Lindstrøm; Joao Boavida; Kjell-Inge Gjesdal; Daehoon Park; Nazli Bahrami; Manouchehr Seyedzadeh; Woldegabriel A Melles; Torill Sauer; Jürgen Geisler; Jonn Terje Geitung
Journal:  Breast Cancer Res Treat       Date:  2020-08-12       Impact factor: 4.624
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.